RL Form 144 Shows 4,206-Share Sale Scheduled with Merrill Lynch
Rhea-AI Filing Summary
Ralph Lauren Corporation (RL) filed a Form 144 disclosing a proposed sale of 4,206 shares of Class A common stock through Merrill Lynch on 08/19/2025, with an aggregate market value of $1,199,608.25. The filing shows those shares were acquired via equity compensation: 621 shares vested on 06/02/2025 and 3,585 shares vested on 08/15/2025. The issuer's reported shares outstanding are 38,693,006. The filing also reports a sale during the past three months of 7,350 shares by Robert Ranftl on 06/04/2025 for gross proceeds of $2,059,569.23. The notice includes the standard representation that the seller knows of no undisclosed material adverse information.
Positive
- Planned sale disclosed with broker, share counts, and timing, supporting transparency under Rule 144
- Shares originated from issuer equity compensation (vesting of performance shares and RSUs), explicitly stated
- Past sale disclosed (7,350 shares on 06/04/2025 for $2,059,569.23), showing continuity of reporting
Negative
- None.
Insights
TL;DR: Routine Rule 144 disclosure of an insider sale from vested equity, modest relative to outstanding shares.
The Form 144 reports a proposed sale of 4,206 Class A shares acquired through equity compensation vesting, scheduled with Merrill Lynch on 08/19/2025. The disclosed past sale of 7,350 shares on 06/04/2025 generated $2,059,569.23. Relative to the issuer's stated 38,693,006 shares outstanding, the transactions are small in percentage terms and are consistent with permitted dispositions under Rule 144. The filing provides transparent transaction timing and source (vesting), which helps investors understand these are compensation-related transfers rather than open-market purchases.
TL;DR: Filing appears to meet Rule 144 disclosure requirements and includes the required seller certification.
The notice identifies the broker, share counts, acquisition dates, and nature of acquisition (vesting of performance shares and RSUs), and includes the seller's certification regarding undisclosed material adverse information. These elements align with Form 144 procedural requirements. No regulatory exceptions, trading-plan dates, or other compliance anomalies are disclosed in the form content provided.